A study by Zhang et al in the Journal of Investigative Dermatology pinpoints a neural IL-17 pathway as the driver of psoriatic itch, reshaping how we think about itch in psoriasis. Through a series of ...

Targeting multiple immune mechanisms may overcome therapy resistance and further improve cancer immunotherapy for humans. The authors of a new article published in Acta Pharmaceutica Sinica B describe ...

A certain biological pathway drives the inflammation seen in the skin disease psoriasis. A certain biological pathway, a set of linked reactions in the body, drives the inflammation seen in the skin ...

The family of interleukin-17 (IL-17) includes six molecules that respond to infection, in addition to participating in various physiological and pathological processes. A new paper in Signal ...

This new article publication from Acta Pharmaceutica Sinica B, discusses cancer immunotherapy with enveloped self-amplifying mRNA CARG-2020 that modulates IL-12, IL-17 and PD-L1 pathways to prevent ...

A certain biological pathway, a set of linked reactions in the body, drives the inflammation seen in the skin disease psoriasis, a new study finds. The work could lead to improved therapies for all ...

“This study provides novel insights into the pathogenesis of OA and suggests a potential therapeutic target in OA treatment.” The concept of osteoarthritis (OA) as a low-grade inflammatory joint ...